Epithelial cell spheroids and methods of making and using the same
Provided are epithelial cell spheroids including spheroids that have apical membranes and cilia that face towards the interior core of the spheroid and spheroids that have apical membranes and cilia that face away from the interior core of the spheroid. Also provided methods of making and using such spheroids.
1. A method of determining an ion channel response to a chemical and/or biological compound, the method comprising:
contacting a spheroid comprising epithelial cells with the chemical and/or biological compound, wherein the spheroid produces mucus; and
responsive to the spheroid being contacted with the chemical and/or biological compound, identifying a physiological response of the spheroid, wherein identifying the physiological response of the spheroid comprises identifying a change in the mucus, and wherein identifying the change in the mucus comprises:
measuring viscoelasticity, pH, and/or mucus solids concentration of the mucus prior to contacting the spheroid with the chemical and/or biological compound,
measuring viscoelasticity, pH, and/or mucus solids concentration of the mucus after contacting the spheroid with the chemical and/or biological compound, and
determining a change in the viscoelasticity, pH, and/or mucus solids concentration for the mucus based on the viscoelasticity, pH, and/or mucus solids concentration prior to and after contacting the spheroid with the chemical and/or biological compound, thereby determining the ion channel response of the spheroid to the chemical and/or biological compound,
wherein the spheroid comprises an interior core and an exterior surface, and a plurality of the epithelial cells have apical membranes that face towards the interior core of the spheroid.
2. The method of claim 1 , wherein the spheroid comprises epithelial cells derived from a subject and the method further comprises predicting identifying the subject's ion channel response to the chemical and/or biological compound based on the ion channel response of the spheroid to the chemical and/or biological compound.
3. The method of claim 2 , wherein the chemical and/or biological compound is effective for treating a channelopathy in the subject.
4. The method of claim 1 , wherein the spheroid comprises epithelial cells that have been expanded in the presence of a ROCK inhibitor and feeder cells.
5. The method of claim 1 , wherein identifying the physiological response of the spheroid further comprises determining a change in morphology for the spheroid.
6. The method of claim 5 , wherein determining the change in morphology for the spheroid comprises:
measuring at least one morphology parameter prior to contacting the spheroid with the chemical and/or biological compound;
measuring the at least one morphology parameter after contacting the spheroid with the chemical and/or biological compound; and
calculating the difference between the at least one morphology parameter prior to and after contacting the spheroid with the chemical and/or biological compound to provide the change in morphology for the spheroid.
7. The method of claim 1 , wherein identifying the physiological response of the spheroid further comprises measuring whether the spheroid shrinks or swells.
8. The method of claim 1 , wherein identifying the physiological response of the spheroid further comprises:
measuring a cilia activity prior to contacting the spheroid with the chemical and/or biological compound;
measuring the cilia activity after contacting the spheroid with the chemical and/or biological compound; and
determining a change in the cilia activity for the spheroid based on the cilia activity prior to and after contacting the spheroid with the chemical and/or biological compound.
9. The method of claim 8 , wherein determining the change in cilia activity for the spheroid further comprises measuring cilia dynamics and determining a change in the cilia dynamics.
10. The method of claim 9 , wherein determining the change in cilia dynamics for the spheroid comprises:
measuring a first average cilia dynamics parameter prior to contacting the spheroid with the chemical and/or biological compound;
measuring a second average cilia dynamics parameter after contacting the spheroid with the chemical and/or biological compound; and
calculating the difference between the first average cilia dynamics parameter and the second average cilia dynamics parameter to provide the change in cilia dynamics for the spheroid.
11. The method of claim 9 , wherein the change in cilia dynamics is an increase in cilia dynamics, and the increase in cilia dynamics is an indication that the chemical and/or biological compound will be effective in modulating a pharmacological response in a subject.
12. The method of claim 1 , wherein the method is a high-throughput method.
13. The method of claim 1 , wherein at least a portion of the epithelial cells are derived from a subject.
14. The method of claim 1 , wherein the epithelial cells comprise airway epithelial cells, nasal epithelial cells, bronchial epithelial cells, and/or alveolar epithelial cells.
15. The method of claim 1 , wherein identifying the change in the mucus comprises:
measuring viscoelasticity of the mucus prior to contacting the spheroid with the chemical and/or biological compound,
measuring viscoelasticity of the mucus after contacting the spheroid with the chemical and/or biological compound, and
determining the change in the viscoelasticity for the mucus based on the viscoelasticity prior to and after contacting the spheroid with the chemical and/or biological compound.
16. The method of claim 1 , wherein identifying the change in the mucus comprises:
measuring pH of the mucus prior to contacting the spheroid with the chemical and/or biological compound,
measuring pH of the mucus after contacting the spheroid with the chemical and/or biological compound, and
determining the change in the pH for the mucus based on the pH prior to and after contacting the spheroid with the chemical and/or biological compound.
17. The method of claim 1 , wherein identifying the change in the mucus comprises:
measuring mucus solids concentration of the mucus prior to contacting the spheroid with the chemical and/or biological compound,
measuring mucus solids concentration of the mucus after contacting the spheroid with the chemical and/or biological compound, and
determining the change in the mucus solids concentration for the mucus based on the mucus solids concentration prior to and after contacting the spheroid with the chemical and/or biological compound.
18. A method of determining an ion channel response to a chemical and/or biological compound, the method comprising:
contacting a spheroid comprising epithelial cells with the chemical and/or biological compound, wherein the spheroid produces mucus; and
responsive to the spheroid being contacted with the chemical and/or biological compound, identifying a physiological response of the spheroid, wherein identifying the physiological response of the spheroid comprises:
measuring a cilia activity prior to contacting the spheroid with the chemical and/or biological compound;
measuring a cilia activity after contacting the spheroid with the chemical and/or biological compound; and
determining a change in cilia activity for the spheroid based on the cilia activity prior to and after contacting the spheroid with the chemical and/or biological compound, thereby determining the ion channel response to the chemical and/or biological compound,
wherein the spheroid comprises an interior core and an exterior surface, and a plurality of the epithelial cells have apical membranes and cilia that face towards the interior core of the spheroid.
19. The method of claim 18 , wherein at least a portion of the epithelial cells are derived from a subject.
20. The method of claim 18 , wherein the epithelial cells comprise airway epithelial cells, nasal epithelial cells, bronchial epithelial cells, and/or alveolar epithelial cells.